We narrowed to 6,076 results for: pAAV

1. pAAV-hSyn-DIO-EGFP (AAV1)

   Viral Prep

   #50457-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   EGFP (Cre-dependent)

   Available Since

   Feb. 18, 2020

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-hSyn-hM4D(Gi)-mCherry (AAV9)

   Viral Prep

   #50475-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSyn-hM4D(Gi)-mCherry (#50475). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM4D(Gi)-mCherry plasmid DNA. hSyn-driven hM4D(Gi) receptor with an mCherry reporter for CNO-induced neuronal inhibition. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   mCherry

   Available Since

   Jan. 26, 2021

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-Syn-ChrimsonR-tdT (AAV1)

   Viral Prep

   #59171-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-Syn-ChrimsonR-tdT (#59171). In addition to the viral particles, you will also receive purified pAAV-Syn-ChrimsonR-tdT plasmid DNA. Syn-driven ChrimsonR-tdTomato expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

   Promoter

   Syn

   Tags

   tdTomato

   Available Since

   Feb. 7, 2018

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-hSyn-DIO-mCherry (AAV8)

   Viral Prep

   #50459-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-hSyn-DIO-mCherry (#50459). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-mCherry plasmid DNA. hSyn-driven, Cre-dependent mCherry-expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   mCherry (Cre-dependent)

   Available Since

   Oct. 3, 2016

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-hSyn-hM3D(Gq)-mCherry (AAV8)

   Viral Prep

   #50474-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-hSyn-hM3D(Gq)-mCherry (#50474). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM3D(Gq)-mCherry plasmid DNA. hSyn-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   Syn

   Tags

   mCherry

   Available Since

   Oct. 3, 2016

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-GFAP-hM3D(Gq)-mCherry (AAV5)

   Viral Prep

   #50478-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-GFAP-hM3D(Gq)-mCherry (#50478). In addition to the viral particles, you will also receive purified pAAV-GFAP-hM3D(Gq)-mCherry plasmid DNA. GFAP-driven hM4D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Bryan Roth

   Promoter

   GFAP

   Tags

   mCherry

   Available Since

   June 19, 2018

   Availability

   Academic Institutions and Nonprofits only

7. pAAV-EF1a-fDIO-Cre (AAV1)

   Viral Prep

   #121675-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Alexander Nectow, Esteban Engel

   Article

   Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30

   Promoter

   EF1a

   Available Since

   Sept. 27, 2023

   Availability

   Academic Institutions and Nonprofits only

8. pAAV-mDlx-NLS-mRuby2 (AAV9)

   Viral Prep

   #99130-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-mDlx-NLS-mRuby2 (#99130). In addition to the viral particles, you will also receive purified pAAV-mDlx-NLS-mRuby2 plasmid DNA. mDlx-driven NLS-mRuby2 expression. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Viviana Gradinaru

   Article

   Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

   Promoter

   mDLX5/6

   Tags

   mRuby2

   Available Since

   Sept. 8, 2020

   Availability

   Academic Institutions and Nonprofits only

9. pAAV-Ef1a-fDIO-GCaMP6s (AAV8)

   Viral Prep

   #105714-AAV8

   Purpose

   Ready-to-use AAV8 particles produced from pAAV-Ef1a-fDIO-GCaMP6s (#105714). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-GCaMP6s plasmid DNA. EF1a-driven, Flp recombinase-dependent expression of GCaMP6s calcium sensor. These AAV preparations are suitable purity for injection into animals

   Depositor

   Rylan Larsen

   Promoter

   Ef1a, Human elongation factor-1 alpha

   Available Since

   Oct. 11, 2019

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-hSyn-hM3D(Gq)-mCherry (AAV9)

    Viral Prep

    #50474-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSyn-hM3D(Gq)-mCherry (#50474). In addition to the viral particles, you will also receive purified pAAV-hSyn-hM3D(Gq)-mCherry plasmid DNA. hSyn-driven hM3D(Gq) receptor with an mCherry reporter for CNO-induced neuronal activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    mCherry

    Available Since

    Jan. 26, 2021

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-TREtight-mTagBFP2-B19G (AAV1)

    Viral Prep

    #100799-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-TREtight-mTagBFP2-B19G (#100799). In addition to the viral particles, you will also receive purified pAAV-TREtight-mTagBFP2-B19G plasmid DNA. Helper virus for monosynaptic tracing with rabies virus; to be coinjected with pAAV-syn-FLEX-splitTVA-EGFP-tTA (Addgene# 100798). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ian Wickersham

    Article

    Liu et al Nature. 2017 Aug 31;548(7669):582-587. d

    Promoter

    TREtight

    Tags

    BFP (in presence of Cre and 100798)

    Available Since

    Dec. 18, 2018

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-hSyn-DIO-EGFP (AAV5)

    Viral Prep

    #50457-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Bryan Roth

    Promoter

    Syn

    Tags

    EGFP (Cre-dependent)

    Available Since

    July 8, 2019

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-flex-taCasp3-TEVp (AAV5)

    Viral Prep

    #45580-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-flex-taCasp3-TEVp (#45580). In addition to the viral particles, you will also receive purified pAAV-flex-taCasp3-TEVp plasmid DNA. EF1a-driven, Cre-dependent, bicicstronic expression of designer pro-taCasp3 and TEVp. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Nirao Shah, Jim Wells

    Article

    Yang et al Cell. 2013 May 9;153(4):896-909. doi: 10

    Promoter

    EF1a

    Available Since

    Sept. 25, 2020

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-CAG-fDIO-mNeonGreen (AAV1)

    Viral Prep

    #99133-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-CAG-fDIO-mNeonGreen (#99133). In addition to the viral particles, you will also receive purified pAAV-CAG-fDIO-mNeonGreen plasmid DNA. CAG-driven, Flp-dependent mNeonGreen expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Viviana Gradinaru

    Article

    Chan et al Nat Neurosci. 2017 Aug;20(8):1172-1179.

    Promoter

    CAG

    Tags

    mNeonGreen (Flp-dependent)

    Available Since

    Jan. 6, 2022

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-S5E2-ChR2-mCherry (AAV9)

    Viral Prep

    #135634-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-S5E2-ChR2-mCherry (#135634). In addition to the viral particles, you will also receive purified pAAV-S5E2-ChR2-mCherry plasmid DNA. Expression of ChR2-mCherry under the control of the E2 regulatory element. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Jordane Dimidschstein

    Article

    Vormstein-Schneider et al Nat Neurosci. 2020 Dec;23(12):1629-1636.

    Tags

    mCherry

    Available Since

    Sept. 15, 2021

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-Ef1a-DIO EYFP (AAV1)

    Viral Prep

    #27056-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-Ef1a-DIO EYFP (#27056). In addition to the viral particles, you will also receive purified pAAV-Ef1a-DIO EYFP plasmid DNA. EF1a-driven, cre-dependent EYFP expression. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Karl Deisseroth

    Tags

    EYFP (Cre-dependent)

    Available Since

    March 16, 2018

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-hIBA1a-GFP-miR124T (AAV5)

    Viral Prep

    #214147-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-hIBA1a-GFP-miR124T (#214147). In addition to the viral particles, you will also receive purified pAAV-hIBA1a-GFP-miR124T plasmid DNA. hIBA1a-driven and miR124T-targeted for microglial inhibition of GFP. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Chun-Li Zhang

    Article

    Serrano et al iScience. 2024 Aug 12;27(9):110706. doi:

    Tags

    GFP

    Available Since

    Sept. 22, 2025

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-mDlx-GFP-Fishell-1 (AAV2)

    Viral Prep

    #83900-AAV2

    Purpose

    Ready-to-use AAV2 particles produced from pAAV-mDlx-GFP-Fishell-1 (#83900). In addition to the viral particles, you will also receive purified pAAV-mDlx-GFP-Fishell-1 plasmid DNA. mDlx-driven expression of GFP in GABA-ergic interneurons. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Gordon Fishell

    Article

    Dimidschstein et al Nat Neurosci. 2016 Oct 31. doi: 10.1038/

    Promoter

    mDlx

    Tags

    GFP

    Available Since

    Aug. 25, 2023

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-Ef1a-fDIO-tdTomato (AAV1)

    Viral Prep

    #128434-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-Ef1a-fDIO-tdTomato (#128434). In addition to the viral particles, you will also receive purified pAAV-Ef1a-fDIO-tdTomato plasmid DNA. EF1a-driven, Flp-dependent expression of tdTomato. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Patricia Jensen

    Article

    Sciolino et al Sci Adv. 2022 Aug 19;8(33):eabn9134. doi

    Promoter

    EF1a

    Tags

    tdTomato (Flp-dependent)

    Available Since

    March 12, 2021

    Availability

    Academic Institutions and Nonprofits only

20. pAAV_hSyn1-SIO-stGtACR2-FusionRed (AAV1)

    Viral Prep

    #105677-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV_hSyn1-SIO-stGtACR2-FusionRed (#105677). In addition to the viral particles, you will also receive purified pAAV_hSyn1-SIO-stGtACR2-FusionRed plasmid DNA. Synapsin-driven, Cre-dependent, soma-targeted anion-conducting channelrhodopsin fused to FusionRed for optogenetic inhibition. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Ofer Yizhar

    Article

    Mahn et al Nat Commun. 2018 Oct 8;9(1):4125. doi: 1

    Promoter

    Syn

    Tags

    FusionRed (Cre-dependent)

    Available Since

    Aug. 17, 2018

    Availability

    Academic Institutions and Nonprofits only